Global Ovarian Cancer Drugs Market size is expected to be worth around USD 9,857 Mn by 2032 from USD 3061 Mn in 2023, growing at a CAGR of 14.3% ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

Compared with endocrine therapy, radiotherapy was associated with a smaller reduction in health-related quality-of-life in ...

Hormonal therapy, namely targeting androgen signaling, has continued to be the mainstay of treatment for advanced prostate cancer, going all the way back to the 1940s when we first started using ...

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs ...

Red light therapy is a type of phototherapy that uses low levels of red light to trigger blood flow and energise cells, which can have healing properties, explains Billy Huh, M.D.

Ovarian Cancer Targeted Medication: PARP Inhibitors, Anti-Angiogenic Drugs, Immunotherapy, and More Ovarian cancer is the malignancy with the highest rate of death from tumors of the female ...

The intersection of radiopharmaceuticals and nanotechnology has propelled the field of medicine forward, particularly concerning targeted cancer therapies.

or hormonal treatments, such as tamoxifen or aromatase inhibitors for breast cancer or androgen ablation for prostate cancer. The effects of chemotherapy-associated cardiovascular toxicity and ...

A PICTURE of Princess Kate taken by six-year-old Prince Louis has been shared by the Princess to mark World Cancer Day. The sweet image - showing Kate beaming in a forest in Windsor with her arms ...

HRT - hormone replacement therapy - is a treatment used to ease menopause symptoms. It replaces the hormones oestrogen and progesterone, which fall to low levels as women approach the menopause.